Coeptis Therapeutics Holdings, Inc.

Nasdaq:COEPNasdaq:COEPW

Finance Services·WEXFORD, PA

CEO

Mehalick David

CFO

Cogley Brian

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-K/A	FY 2024	12/31/24	6/3/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/28/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

News (8-K)

47 shown

Filed	Type	Description
2/12/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/4/26	Vote	Submission of Matters to a Vote of Security Holders	→
1/16/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
4/28/25	Agreement	Entry into a Material Definitive Agreement	→
3/27/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/24/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/29/26	424B3	424B3	→
1/5/26	424B3	424B3	→
12/22/25	S-4/A	AMENDMENT NO 5	→
12/10/25	S-4/A	FORM S-4 AMENDMENT 4	→
11/14/25	424B3	424B3	→
11/14/25	424B3	424B3	→
↓

Filing History(302 filings)

TypeDateAccessionPeriodSize

Feb 13, 2026

0001683168-26-001032

Feb 11, 2026

6.4 KB

Feb 13, 2026

0001683168-26-001031

Feb 11, 2026

6.4 KB

Feb 13, 2026

0001683168-26-001030

Feb 11, 2026

6.7 KB

Feb 13, 2026

0001683168-26-001029

Feb 11, 2026

6.4 KB

Feb 13, 2026

0001683168-26-001026

Feb 11, 2026

6.4 KB

Feb 13, 2026

0001683168-26-001028

Feb 11, 2026

6.4 KB

Feb 13, 2026

0001683168-26-001025

Feb 11, 2026

6.5 KB

Feb 13, 2026

0001683168-26-001027

Feb 11, 2026

6.3 KB

Feb 13, 2026

0001683168-26-001024

Feb 11, 2026

6.4 KB

8-K

Feb 12, 2026

0001683168-26-000963FORM 8-K

Feb 9, 2026

240.0 KB

8-K

Feb 4, 2026

0001683168-26-000751FORM 8-K

Jan 30, 2026

256.8 KB

SCHEDULE 13G

Jan 30, 2026

0000102909-26-000137

—

8.6 KB

424B3

Jan 29, 2026

0001683168-26-000618FORM 424B3

—

18.2 KB

DEFA14A

Jan 29, 2026

0001683168-26-000617DEFINITIVE ADDITIONAL MATERIALS

—

28.9 KB

8-K

Jan 16, 2026

0001683168-26-000370CURRENT REPORT

Jan 12, 2026

236.4 KB

424B3

Jan 5, 2026

0001683168-26-000105FORM 424B3

—

6.6 MB

EFFECT

Dec 23, 2025

9999999995-25-003895

—

1.8 KB

S-4/A

Dec 22, 2025

0001683168-25-009287AMENDMENT NO 5

—

14.8 MB

144

Dec 15, 2025

0001959173-25-007733

—

4.4 KB

S-4/A

Dec 10, 2025

0001683168-25-009045FORM S-4 AMENDMENT 4

—

14.8 MB

424B3

Nov 14, 2025

0001683168-25-008463FORM 424B3

—

652.8 KB

424B3

Nov 14, 2025

0001683168-25-008464FORM 424B3

—

653.2 KB

424B3

Nov 14, 2025

0001683168-25-008462FORM 424B3

—

652.7 KB

10-Q

Nov 14, 2025

0001683168-25-008341FORM 10-Q FOR SEP 2025

Sep 30, 2025

6.6 MB

S-4/A

Oct 3, 2025

0001683168-25-007407AMENDMENT NO. 3

—

14.5 MB

25 filings shown

Filed	Form	Description
1/29/26	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
11/14/24	DEF 14A	DEF 14A	→
11/4/24	PRE 14A	PRELIMINARY PROXY	→
11/17/23	DEF 14A	DEF 14A	→
11/7/23	PRE 14A	PRELIMINARY PROXY STATEMENT	→
10/11/22	DEF 14A	DEFINITIVE PROXY STATEMENT	→
↓

Coeptis Therapeutics Holdings, Inc.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(302 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
↓

Filed	Form	Description
1/30/26	SCHEDULE 13G	SCHEDULE 13G	→
12/23/25	EFFECT	EFFECT	→
12/15/25	144	144	→
9/2/25	144	144	→
8/7/25	D	D	→
4/21/25	EFFECT	EFFECT	→
↓